Riskpilot← Back to searchSign inGet full accessAktieselskabet af 1. juni 2011 II
A/SActiveCVR 33752245Philip Heymans Alle 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 2011— employees
Revenue 2025
—
EBITDA margin
—
-4% vs 2024
Equity ratio
99.2%
Financial strength
Net profit 2025
DKK 45K
-57% vs 2024
| Revenue | — | — |
| EBITDA | DKK -17K | -4% |
| Net profit | DKK 45K | -57% |
| Total assets | DKK 4,1M | +2% |
| Equity | DKK 4,1M | +1% |
| Employees | — | — |
Legal name
Aktieselskabet af 1. juni 2011 II
CVR number
33752245
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30. maj 2011
Share capital
DKK 1.000.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med en direktør eller i forening med et andet bestyrelsesmedlem.
Company purpose
Selskabets formål er at drive forskning, handel, fabrikation og dermed beslægtet virksomhed primært inden for medicinal-branchen.
Address
Philip Heymans Alle 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | 0 | 0 | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -10 | -12 | -14 | -13 | -13 | -15 | -130 | -57 | -15 | -15 | -14 | -28 | -17 | -17 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -10 | -12 | -14 | -13 | -13 | -15 | -130 | -57 | -15 | -15 | -14 | -28 | -17 | -17 |
| Net financials | -0 | -1 | 0 | -2 | -3 | -3 | 1.786 | -26 | -21 | -19 | 1 | 106 | 122 | 64 |
| Profit before tax | -10 | -13 | -14 | -15 | -16 | -18 | 1.656 | -83 | -36 | -34 | -13 | 78 | 105 | 47 |
| Tax | -3 | -3 | -3 | -4 | -3 | 4 | -0 | -116 | -0 | -0 | -0 | -0 | -0 | 1 |
| Net profit | -8 | -10 | -10 | -12 | -13 | -22 | 1.656 | 33 | -36 | -34 | -13 | 78 | 105 | 45 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.286 | 2.288 | 2.278 | 2.266 | 2.253 | 2.233 | 4.004 | 3.936 | 3.887 | 3.853 | 3.841 | 3.932 | 4.026 | 4.088 |
| Equity | 2.286 | 2.276 | 2.266 | 2.254 | 2.241 | 2.218 | 3.875 | 3.908 | 3.872 | 3.838 | 3.826 | 3.904 | 4.009 | 4.054 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 13 | 13 | 13 | 13 | 15 | 130 | 29 | 15 | 15 | 15 | 29 | 17 | 34 |
| Total debt | 0 | 13 | 13 | 13 | 13 | 15 | 130 | 29 | 15 | 15 | 15 | 29 | 17 | 34 |
EBITDA margin
-1725000.0%
This company
15.8%
Market median
-10917822% vs market
20122025
Equity ratio
99.2%
This company
38.2%
Market median
+160% vs market
20122025
Return on equity
1.1%
This company
18.4%
Market median
-94% vs market
20122025
Net profit margin
4536900.0%
This company
8.1%
Market median
+56011011% vs market
20122025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CS Management | Management | 2011 | — | — |
HJ Management | Management | 2018 | — | — |
OL Management | Management | 2011 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2011 | — | — | |
| Chairman | 2011 | — | — | |
| Chairman | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BAVARIAN NORDIC A/S | Company | 100.0% | 100.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Arbejdsmarkedets Tillægspension
Aktieselskabet af 1. juni 2011 II Board members of Aktieselskabet af 1. juni 2011 II also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Caroline Sundorph Pontoppidan | Management | 0 companies |
| Henrik Juuel | Management | 0 companies |
| Ole Larsen | Management | 0 companies |
| Henrik Møgelmose | Board of Directors | 0 companies |
| Christian Boje Vilstrup | Board of Directors | 0 companies |
| Morten Max Rasmussen | Board of Directors | 0 companies |
| Michael Egede Budtz | Chairman | 0 companies |
| Anders Hedegaard | Chairman | 0 companies |
| Paul John Chaplin | Chairman | 0 companies |